参考文献(References)：
[1] World Health Organization.Coronavirus disease (COVID-19)[EB/OL].(2023-08-09) [2024-02-29].https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-%28co-vid-19%29.
[2] World Health Organization.Vaccine efficacy,effectiveness and protection[EB/OL].(2021-07-14) [2024-02-29].https://www.who.int/news-room / feature-stories / detail / vaccine-efficacy-effectiveness-and-protection.
[3] YUAN J H,XU Y C,WONG I O L,et al.Dynamic predictors of COVID-19 vaccination uptake and their interconnections over two years in Hong Kong[J].Nature Communications,2024,15(1):290.
[4] NOTMAN N.Teaching old drugs new tricks to treat COVID-19[J].Nature Synthesis,2022,1(1):2.
[5] WU R Y,WANG L J,KUO H C D,et al.An update on current therapeutic drugs treating COVID-19[J].Current Pharmacology Reports,2020,6:56.
[6] LI G D,HILGENFELD R,WHITLEY R,et al.Therapeutic strategies for COVID-19:progress and lessons learned[J].Nature Reviews Drug Discovery,2023,22:449.
[7] CHEN J Y,LI Z,GUO J H,et al.SARS-CoV-2 nsp5 exhibits stronger catalytic activity and interferon antagonism than its SARS-CoV ortholog[J].Journal of Virology,2022,96(8):e00037-22.
[8] ZHENG Y,DENG J,HAN L L,et al.SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules[J].Signal Transduction and Targeted Therapy,2022,7(1):2-8.
[9] LIU Y Z,QIN C,RAO Y L,et al.SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS to evade the innate immune response[J].mBio,2021,12(5):e0233521.
[10] SCHIMUNEK J,SEIDL P,ELEZ K,et al.A community effort in SARS-CoV-2 drug discovery[J].Molecular Informatics,2024,43(1):e202300262.
[11] KORNS M,DHAMOTHARAN K,JEFFRIES C M,et al.The preference signature of the SARS-CoV-2 nucleocapsid NTD for its 5’-genomic RNA elements[J].Nature Communications,2023,14(1):3331.
[12] ZIMMERMAN M I,BOWMAN G.SARS-CoV-2 simulations go exascale to capture spike opening and reveal cryptic pockets across the proteome[J].Biophysical Journal,2021,120(3):299a.
[13] VISTOLI G,MANELFI C,TALARICO C,et al.MEDIATE-Molecular DockIng at homE:turning collaborative simulations into therapeutic solutions[J].Expert Opinion on Drug Discovery,2023,18(8):821.
[14] GADIOLI D,VITALI E,FICARELLI F,et al.EXSCALATE:an extreme-scale virtual screening platform for drug discovery targeting polypharmacology to fight SARS-CoV-2[J].IEEE Transactions on Emerging Topics in Computing,2022,11(1):170.
[15] ALTINCEKIC N,JORES N,L?HR F,et al.Targeting the main protease (Mpro,nsp5) by growth of fragment scaffolds exploiting structure-based methodologies[J].ACS Chemical Biology,2024,19(2):563.
[16] ?ZDEMIR M,K?KSOY B,CEYHAN D,et al.Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes[J].Journal of Biomolecular Structure and Dynamics,2022,40(11):4905.
[17] CHEN K Y,KRISCHUNS T,VARGA L O,et al.A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors[J].Antiviral Research,2022,201:105272.
[18] HAKAMI A R,BAKHEIT A H,ALMEHIZIA A A,et al.Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening[J].Future Medicinal Chemistry,2022,14(2):61.
[19] LYU M,FAN G W,XIAO G X,et al.Traditional Chinese medicine in COVID-19[J].Acta Pharmaceutica Sinica B,2021,11(11):3337.
[20] WANG W Y,XIE Y,ZHOU H,et al.Contribution of traditional Chinese medicine to the treatment of COVID-19[J].Phytomedicine,2021,85:153279.
[21] HUANG Y F,BAI C,HE F,et al.Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19)[J].Pharmacological Research,2020,158:104939.
[22] DE SOUZA NETO L R,MOREIRA-FILHO J T,NEVES B J,et al.In silico strategies to support fragment-to-lead optimization in drug discovery[J].Frontiers in Chemistry,2020,8:93.
[23] WALSH M A,GRIMES J M,STUART D I.Diamond light source:contributions to SARS-CoV-2 biology and therapeutics[J].Biochemical and Biophysical Research Communications,2021,538:40.
[24] GALLO K,KEMMLER E,GOEDE A,et al.SuperNatural 3.0:a database of natural products and natural product-based derivatives[J].Nucleic Acids Research,2023,51(D1):D654-D655.
[25] THORNBURG C C,BRITT J R,EVANS J R,et al.NCI program for natural product discovery:a publicly-accessible library of natural product fractions for high-throughput screening[J].ACS Chemical Biology,2018,13(9):2484.
[26] HUANG L,XIE D L,YU Y R,et al.TCMID 2.0:a comprehensive resource for TCM[J].Nucleic Acids Research,2018,46(D1):D1117.
[27] KIM S,CHEN J,CHENG T,et al.PubChem 2023 update[J].Nucleic Acids Research,2023,51(D1):D1373.
[28] LIU T Q,LIN Y,WEN X,et al.BindingDB:a web-accessible database of experimentally determined protein-ligand binding affinities[J].Nucleic Acids Research,2007,35(Suppl 1):D198.
[29] TROTT O,OLSON A J.AutoDock Vina:improving the speed and accuracy of docking with a new scoring function,efficient optimization,and multithreading[J].Journal of Computational Chemistry,2010,31(2):455-461.
[30] TANG S D,CHEN R Q,LIN M R,et al.Accelerating autodock vina with GPUs[J].Molecules,2022,27(9):3041.
[31] FRIEDMAN J H.Greedy function approximation:a gradient boosting machine[J].Annals of Statistics,2001,29(5):1189.
[32] RASHMI K V,GILAD-BACHRACH R.DART:dropouts meet multiple additive regression trees[EB/OL].(2015-05-07) [2024-02-29].http://arxiv.org/abs/1505.01866.DOI:10.48550/arXiv.1505.01866.
[33] LIAW R,LIANG E,NISHHARA R,et al.Tune:a research platform for distributed model selection and training[EB/OL].(2018-07-13) [2024-02-29].https://doi.org/10.48550/arXiv.1807.05118.
[34] BENTO A P,HERSEY A,FELIX E,et al.An open source chemical structure curation pipeline using RDKit[J].Journal of Cheminformatics,2020,12:1.
[35] O’BOYLE N M,BANCK M,JAMES C A,et al.Open Babel:an open chemical toolbox[J].Journal of Cheminformatics,2011,3:1.
[36] RINIKER S,LANDRUM G A.Better informed distance geometry:using what we know to improve conformation generation[J].Journal of Chemical Information and Modeling,2015,55(12):2562.
[37] RAPPE A K,CASEWIT C J,COLWELL K S,et al.UFF:a full periodic table force field for molecular mechanics and molecular dynamics simulations[J].Journal of the American Chemical Society,1992,114(25):10024.
[38] TANG S D,DING J,ZHU X Y,et al.Vina-GPU 2.1:towards further optimizing docking speed and precision of AutoDock Vina and its derivatives[EB/OL].(2023-11-05) [2024-02-29].https://doi.org/10.1101/2023.11.04.565429.
[39] EASTMAN P,SWAILS J,CHODERA J D,et al.OpenMM 7:rapid development of high performance algorithms for molecular dynamics[J].PLoS Computational Biology,2017,13(7):e1005659.
[40] MAIER J A,MARTINEZ C,KASAVAJHALA K,et al.ff14SB:improving the accuracy of protein side chain and backbone parameters from ff99SB[J].Journal of Chemical Theory and Computation,2015,11(8):3696.
[41] DARDEN T,YORK D,PEDERSEN L.Particle mesh Ewald:an N log (N) method for Ewald sums in large systems[J].The Journal of Chemical Physics,1993,98(12):10089.
[42] ESTER M,KRIEGEL H P,SANDER J,et al.A density-based algorithm for discovering clusters in large spatial databases with noise[C]//Proceedings of the 2nd International Conference on Knowledge Discovery and Data Mining,KDD 1996.Palo Alto:AAAI Press,1996:226.
[43] HU H F,YANG Y,YIN Y M,et al.Metric learning for domain adversarial network[J].Frontiers of Computer Science,2022,16(5):165341.
